We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

ITC Takes On “Anti-Terror” Small Pox Vaccine Patent Dispute

Law360 (September 22, 2005, 12:00 AM EDT) -- With millions of dollars in government anti-terror funds at stake, the International Trade Commission has launched an investigation into small-pox vaccine patent infringement alleged by Danish biopharmaceutical firm Bavarian-Nordic.

Bavarian Nordic accused U.K.-based Acambis Inc. in August of patent infringement and misappropriation of trade secrets, filing its complaint with the ITC and in the U.S. District Court for the District of Delaware.

The parties are the only two companies working on a specially-weakened, hence safer, version of the smallpox vaccine. Bavarian alleges Acambis is producing its...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.